These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2335229)

  • 1. The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion.
    Miyasaka K; Funakoshi A; Kitani K; Tamamura H; Fujii N; Funakoshi S
    FEBS Lett; 1990 Apr; 263(2):279-80. PubMed ID: 2335229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Pancreastatin inhibits central vagal nerve stimulation.
    Miyasaka K; Funakoshi A; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Gastroenterology; 1990 Dec; 99(6):1751-6. PubMed ID: 1977653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas.
    Funakoshi A; Miyasaka K; Kitani K; Tamamura H; Funakoshi S; Yajima H
    Biochem Biophys Res Commun; 1989 Feb; 158(3):844-9. PubMed ID: 2645871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of pancreastatin on insulin secretion and the exocrine pancreas in rats].
    von Schönfeld J; Müller MK; Neisius I; Geling M; Rünzi M; Goebell H
    Z Gastroenterol; 1991 Oct; 29(10):523-6. PubMed ID: 1781189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats.
    Miyasaka K; Funakoshi A; Yasunami Y; Nakamura R; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Regul Pept; 1990 Apr; 28(2):189-98. PubMed ID: 1693005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity of synthetic human pancreastatin on exocrine pancreas.
    Funakoshi A; Miyasaka K; Nakamura R; Kitani K; Funakoshi S; Tamamura H; Fujii N; Yajima H
    Biochem Biophys Res Commun; 1988 Nov; 156(3):1237-42. PubMed ID: 3190702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of bovine pancreastatin.
    Nakano I; Funakoshi A; Miyasaka K; Ishida K; Makk G; Angwin P; Chang D; Tatemoto K
    Regul Pept; 1989 May; 25(2):207-13. PubMed ID: 2756155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreastatin: characterization of biological activity.
    Zhang T; Mochizuki T; Kogire M; Ishizuka J; Yanaihara N; Thompson JC; Greeley GH
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1157-60. PubMed ID: 2268319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat.
    Miyasaka K; Funakoshi A; Nakamura R; Kitani K; Shimizu F; Tatemoto K
    Digestion; 1989; 43(4):204-11. PubMed ID: 2612743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of pancreastatin on pancreatic exocrine secretion in vivo and in vitro].
    Miyasaka K; Nakamura R; Funakoshi A; Kitani K
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jun; 86(6):1299-303. PubMed ID: 2477573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity of human pancreastatin and its localization in pancreas.
    Funakoshi A; Jimi A; Yasunami Y; Tateishi K; Funakoshi S; Tamamura H; Yajima H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):913-8. PubMed ID: 2649103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synthetic human pancreastatin on pancreatic secretion and blood flow in rats and dogs.
    Doi R; Inoue K; Hosotani R; Higashide S; Takaori K; Funakoshi S; Yajima H; Rayford PL; Tobe T
    Peptides; 1991; 12(3):499-502. PubMed ID: 1717953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
    Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
    Ahrén B; Pierzynowski SG; Weström B; Karlsson B
    Diabetes Res; 1990 Jun; 14(2):93-6. PubMed ID: 2134219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of pancreastatins from the porcine digestive tract.
    Jensen TD; Holst JJ; Fahrenkrug J
    Scand J Gastroenterol; 1994 Apr; 29(4):376-84. PubMed ID: 8047816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
    Ahrén B; Bertrand G; Roye M; Ribes G
    Acta Physiol Scand; 1996 Sep; 158(1):63-70. PubMed ID: 8876749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreastatin--a novel regulatory peptide?
    Schmidt WE; Creutzfeldt W
    Acta Oncol; 1991; 30(4):441-9. PubMed ID: 1854501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogenolytic effect of pancreastatin in the rat.
    Sanchez V; Calvo JR; Goberna R
    Biosci Rep; 1990 Feb; 10(1):87-91. PubMed ID: 2187544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glucose-stimulated insulin release in the perfused rat pancreas by parathyroid secretory protein-I (chromogranin-A).
    Greeley GH; Thompson JC; Ishizuka J; Cooper CW; Levine MA; Gorr SU; Cohn DV
    Endocrinology; 1989 Mar; 124(3):1235-8. PubMed ID: 2645112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.